Showing results (721-730 of 1,835) with videos related to

Sort By:
Pageof 184
Onkologie|February 9, 2005
A mouse model of oral-esophageal carcinogenesisOliver G Opitz, Michael Quante, Alexander von Werder, et al.
Onkologie|December 9, 2004
Phase II study of single-agent pegylated liposomal doxorubicin HCl (PLD) in metastatic breast cancer after first-line treatment failureB Mlineritsch, P Mayer, C Rass, et al.
Onkologie|December 9, 2004
Second-line treatment of advanced colorectal cancer with a weekly simultaneous 24-hour infusion of 5-fluorouracil and sodium-folinate: a multicentre phase II trialJ Kuhfahl, C Steinbrecher, T Wagner, et al.
Onkologie|February 13, 2008
Unusual discordant responses in two multiple myeloma patients during bortezomib treatmentMaria Teresa Pirrotta, Alessandro Gozzetti, Alfonso Cerase, et al.
Onkologie|February 13, 2008
Cancer of the urinary bladder neovagina in a patient with Morris' syndromeMiroslaw Wielgos, Iwona Szymusik, Agnieszka Banaszek, et al.
Onkologie|March 7, 2008
Postoperative sense of well-being and quality of life in breast cancer patients do not depend on type of primary surgeryMathias Warm, Caroline Gatermann, Ronald Kates, et al.
Onkologie|March 7, 2008
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomographyBernd Kasper, Sascha Dietrich, Antonia Dimitrakopoulou-Strauss, et al.
Onkologie|March 7, 2008
Isolated bone marrow natural killer cell lymphoma with central nervous system involvement mimicking a cerebral infarctIbrahim Adaletli, Celalettin Camci, Alper Sevinc, et al.
Onkologie|December 8, 2007
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II studySimone Steinbild, Jann Arends, Michael Medinger, et al.
Onkologie|December 8, 2007
Severe hyponatremia in a patient with mantle cell lymphoma treated with bortezomib: a case report and review of the literatureStefan Brodmann, Evelyne Gyr Klaas, Richard Cathomas, et al.
Pageof 184